Erasca, Inc. (ERAS) vs Merit Medical Systems, Inc. (MMSI)

A side-by-side comparison of Erasca, Inc. and Merit Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ERAS vs MMSI

growth of $100 · dividends reinvested · last 5y
ERAS -15.5% (-3.3%/yr)MMSI +37.1% (+6.5%/yr)MMSI compounded faster over this window
050100150Start $10020222023202420252026$84$137
ERAS MMSI

ERAS vs MMSI: by the numbers

  • •MMSI is the larger company ($5.07B vs $4.96B market cap).
  • •MMSI is profitable (9.22% net margin) while ERAS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricERASMMSI
P/E ratioN/A35.11
Forward P/EN/A19.75
P/S ratioN/A3.21
P/B ratio13.723.02
EV / EBITDAN/A16.14
FCF yieldN/A4.01%

Profitability

MetricERASMMSI
Gross margin0.00%49.52%
Operating margin0.00%12.75%
Net margin0.00%9.22%
ROE-79.37%8.67%
ROIC-38.03%5.80%

Growth (annualized)

MetricERASMMSI
Revenue CAGR (5Y)N/A8.90%
FCF CAGR (5Y)N/A8.96%
Total return CAGR (5Y)-8.34%3.88%

Frequently asked

Is ERAS or MMSI more profitable?
MMSI runs the higher net margin — ERAS at 0.00% versus MMSI at 9.22%.
How have ERAS and MMSI total returns compared?
Over the past 5 years, ERAS delivered -8.34% and MMSI delivered 3.88% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.